Affimed NV
(NASDAQ:AFMD)
$0.462
-0.0143[-3.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$0.462
0[0.00%]
Open0.480Close0.462
Vol / Avg.516.731K / 882.374KMkt Cap68.995M
Day Range0.455 - 0.48052 Wk Range0.451 - 2.545

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

Affimed Stock (NASDAQ:AFMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Overweight

Highest Price Target1

$15.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.36

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
55100

Analyst Firms Making Recommendations1

  • Cantor Fitzgerald
  • Truist Securities
  • HC Wainwright & Co.
  • Berenberg
  • Wells Fargo

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Affimed

All Ratings (25)

Upgrades (0)

Downgrades (1)

Initiations (6)

Q

What is the target price for Affimed (AFMD)?

A

The latest price target for Affimed (NASDAQ: AFMD) was reported by Cantor Fitzgerald on September 12, 2023. The analyst firm set a price target for $7.00 expecting AFMD to rise to within 12 months (a possible 1415.15% upside). 15 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ: AFMD) was provided by Cantor Fitzgerald, and Affimed reiterated their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a reiterated with a price target of $0.00 to $7.00. The current price Affimed (AFMD) is trading at is $0.46, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.